Zobrazeno 81 - 90
of 5 689
pro vyhledávání: ''
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background Multiple myeloma (MM) is a major health concern. Understanding the different burden and tendency of MM in different regions is crucial for formulating specific local strategies. Therefore, we evaluated the epidemiologic patterns and explor
Autor:
Shigenori Kakutani, Taro Teshima, Yuta Yamada, Yuji Hakozaki, Yoshiyuki Akiyama, Tetsuya Fujimura, Naoki Kimura, Yuta Takeshima, Taketo Kawai, Daisuke Yamada, Yusuke Sato, Haruki Kume
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Cancer
BMC Cancer
Background The objective of this study is to investigate the clinical significance and risk factors of upgrading in the International Society of Urological Pathology (ISUP) Grade Group System in men undergoing robot-assisted radical prostatectomy (RA
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background Primary hepatic neuroendocrine tumors (PH-NETs) are extremely rare and unknown. Because of its rarity, its prognosis features and influencing factors are not well established. Methods Data of 140 patients with PH-NETs diagnosed in the SEER
Autor:
Emma Hudson, Amerah Amin, Jason Francis Lester, Vaneet Nayar, Xiaohui Zhuo, Adeline Durand, Peter Martin, Andrew Conn, Ceri Powell, C. Escriu, Lauren Nelless, Samuel Chan, Xinke Zhang, Vivek Pawar, Talal Mansy, John Conibear, Juliet Brock, Sarah Khan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background The treatment landscape for advanced non-small cell lung cancer (aNSCLC) has evolved rapidly since immuno-oncology (IO) therapies were introduced. This study used recent data to assess real-world treatment patterns and clinical outcomes in
Autor:
Haixiao Wu, Xu Guo, Wenjuan Ma, Zheng Liu, Vladimir P. Chekhonin, Dezheng Wang, Chao Zhang, Jin Zhang, Yao Xu, Shuang Zhang, Karl Peltzer, Xin Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background This study aimed to describe the incidence, clinical characteristics, and prognosis of lung cancer patients with synchronous bone metastasis (SBM) and to analyze the prognostic factors of the lung cancer patients with SBM. Methods A total
Autor:
David Weller, Lovney Kanguru, Christine Campbell, Annemieke Bikker, David H. Brewster, Karen Barnett, Debbie Cavers, Rhona Duff
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
Cavers, D, Campbell, C, Brewster, D, Weller, D, Bikker, A, Kanguru, L, Barnett, K & Duff, R 2021, ' Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study ', BMC Cancer, vol. 21, no. 496, 496 . https://doi.org/10.1186/s12885-021-08238-0
BMC Cancer
Cavers, D, Campbell, C, Brewster, D, Weller, D, Bikker, A, Kanguru, L, Barnett, K & Duff, R 2021, ' Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study ', BMC Cancer, vol. 21, no. 496, 496 . https://doi.org/10.1186/s12885-021-08238-0
Background More people are surviving a first primary cancer and experiencing a second, different cancer. However, little is known about the diagnostic journeys of patients with second primary cancer (SPC). This study explores the views of patients an
Autor:
Floriana Morgillo, Giovanna Esposito, Gianfranco Mancuso, Francesco Perrone, Fortunato Ciardiello, Maria Carmela Piccirillo, Paolo Maione, Clorinda Schettino, Cesare Gridelli, Raimondo Di Liello, Piera Gargiulo, Vittorio Gebbia, Giuliano Palumbo, Massimo Di Maio, Adriano Gravina, Alessia Spagnuolo, Laura Arenare, Alessandro Morabito, Carminia Maria Della Corte, Ciro Gallo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background Chemotherapy-induced neutropenia (CIN) has been demonstrated to be a prognostic factor in several cancer conditions. We previously found a significant prognostic value of CIN on overall survival (OS), in a pooled dataset of patients with a
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background We identified differentiated thyroid cancer (DTC) survivors from SEER registries and performed Poisson regression to calculate the relative risks (RRs) of subsequent malignancies (SMs) by different sites associated with radioactive iodine
Autor:
Shidai Jin, Renhua Guo, Fangyan Gao, Liang Chen, Zhihong Zhang, Qianqian Wang, Jingya Zhang, Wen Gao, Fan Lin, Chen Zhang, Tianyu Qu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
Background To compare the benefits and explore the cause of acquired resistance of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and its combination with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients har
Autor:
Morgan Quinley, Jessica M. Orgusyan, Bernard M. H. Law, Carmen W.H. Chan, Carissa W. Y. Wong, Mary M.Y. Waye, Ka Ming Chow, Marques S N Ng, Corinna C. Y. Wong
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
BMC Cancer
BMC Cancer
Background Adjuvant endocrine therapies are known to induce undesirable adverse effects such as vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients. Drugs used in these therapies are often metabolised by cytochrome P450 (CYP)